Boya Bio: Controlling shareholder nears share increase target

Boya Bio-Pharmaceutical Group (SZSE:300294) announced that its controlling shareholder, China Resources Pharmaceutical Holdings, has increased its holdings in the company. From November 8, 2024, to April 8, 2025, China Resources Pharmaceutical Holdings accumulated 5,899,700 shares via centralized bidding through the Shenzhen Stock Exchange, representing 1.17% of Boya Bio's total share capital. This increase is part of a larger plan announced in December 2024, where China Resources aims to increase its stake by at least 1% (5,042,400 shares) and up to 1.2% (6,050,900 shares) of the company's total share capital, with funding from its own funds or self-raised funds. Following the share increase, China Resources Pharmaceutical Holdings holds 30.4493% of Boya Bio's total share capital.